Burning Rock Biotech (BNR) Income from Discontinued Operations (2021 - 2022)
Burning Rock Biotech (BNR) posted quarterly Income from Discontinued Operations of 276000.0 for Q4 2022, down 253.31% year-over-year from 180027.44 in Q4 2021, and down 2023.08% quarter-over-quarter from 13000.0 in Q2 2022.
Burning Rock Biotech (BNR) Income from Discontinued Operations (2021 - 2022) Analysis & Trends
Burning Rock Biotech's Income from Discontinued Operations history runs 2 years deep, the most recent figure standing at 276000.0 for Q4 2022.
- In Q4 2022, Income from Discontinued Operations fell 253.31% year-over-year to 276000.0; the TTM figure through Dec 2022 stood at 174514.75 (changed N/A YoY), while the FY2022 annual figure was 283130.63, down 258.67% from the prior year.
- Income from Discontinued Operations for Q4 2022 stood at 276000.0, down from 13000.0 in the prior quarter.
- The five-year high for Income from Discontinued Operations was 180027.44 in Q4 2021, with the low at 276000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.77 Bn | 209.71 Bn | 8.34 Bn | - |
| 2 | Danaher | 139.78 Bn | 135.43 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.04 Bn | 45.85 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.68 Bn | 37.88 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.34 Bn | 37.26 Bn | 1.44 Bn | - |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn | - |
| 7 | Illumina | 29.90 Bn | 28.73 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.58 Bn | 28.53 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | - |
| 10 | Burning Rock Biotech | 781.17 Mn | 711.04 Mn | 11.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -276,000.00 |
| Jun 30, 2022 | -13,000.00 |
| Dec 31, 2021 | 180,027.44 |
| Sep 30, 2021 | -65,542.19 |
| Jun 30, 2021 | -251,632.82 |